The discovery of 2-substituted phenol quinazolines as potent RET kinase inhibitors with improved KDR selectivityRebecca Newton, Donald Ogilvie, Stuart Jones et al.|European Journal of Medicinal Chemistry|2016Cited by 40
Identification of selective inhibitors of RET and comparison with current clinical candidates through development and validation of a robust screening cascadeAmanda J. Watson, Donald Ogilvie, Gemma V. Hopkins et al.|F1000Research|2016Cited by 6
Identification of selective inhibitors of RET and comparison with current clinical candidates through development and validation of a robust screening cascadeAmanda J. Watson, Donald Ogilvie, Gemma V. Hopkins et al.|F1000Research|2016Cited by 6
Abstract 778: The identification and structure-guided optimisation of potent and selective inhibitors of oncogenes in medullary thyroid carcinoma and lung adenocarcinomaRoger J. Butlin, Donald Ogilvie, Rebecca Newton et al.|Cancer Research|2015Cited by 0
Datasets: selective inhibitors of RET and comparison with current clinical candidates through development and validation of a robust screening cascadeAmanda J. Watson, Donald Ogilvie, Gemma V. Hopkins et al.|Unknown|2025Cited by 0